NASDAQ:AVXL   Anavex Life Sciences Corp.
FDA just approved stage 2 of clinical trial and technical analysis looks really good.

Here are some targets for some really nice returns
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.